Jon Packham

6.0k total citations
115 papers, 3.1k citations indexed

About

Jon Packham is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Jon Packham has authored 115 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Rheumatology, 53 papers in Immunology and 37 papers in Hematology. Recurrent topics in Jon Packham's work include Spondyloarthritis Studies and Treatments (55 papers), Rheumatoid Arthritis Research and Therapies (43 papers) and Psoriasis: Treatment and Pathogenesis (41 papers). Jon Packham is often cited by papers focused on Spondyloarthritis Studies and Treatments (55 papers), Rheumatoid Arthritis Research and Therapies (43 papers) and Psoriasis: Treatment and Pathogenesis (41 papers). Jon Packham collaborates with scholars based in United Kingdom, United States and Ireland. Jon Packham's co-authors include Derek L. Mattey, Kirstie Haywood, Kelvin P. Jordan, Neil McHugh, P. T. Dawes, Emma L. Healey, Anne Barton, Ann Brownfield, Edward Flynn and Andrew Garratt and has published in prestigious journals such as The Lancet, PLoS ONE and Scientific Reports.

In The Last Decade

Jon Packham

107 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Packham United Kingdom 32 1.7k 1.3k 1.2k 423 382 115 3.1k
Sarah Ringold United States 28 841 0.5× 1.6k 1.3× 377 0.3× 647 1.5× 422 1.1× 85 2.9k
Marisa S. Klein‐Gitelman United States 28 1.3k 0.8× 547 0.4× 651 0.6× 234 0.6× 212 0.6× 76 2.3k
Johannes‐Peter Haas Germany 27 394 0.2× 873 0.7× 502 0.4× 389 0.9× 561 1.5× 183 2.3k
Davinder Singh‐Grewal Australia 25 685 0.4× 530 0.4× 292 0.2× 443 1.0× 192 0.5× 86 2.3k
Sophia Steer United Kingdom 30 1.8k 1.1× 682 0.5× 725 0.6× 77 0.2× 371 1.0× 62 3.5k
T. Brent Graham United States 28 582 0.3× 787 0.6× 381 0.3× 324 0.8× 173 0.5× 53 2.3k
Johanna M W Hazes Netherlands 32 2.8k 1.7× 1.0k 0.8× 608 0.5× 67 0.2× 156 0.4× 80 3.7k
Eileen Baildam United Kingdom 27 518 0.3× 1.1k 0.9× 325 0.3× 751 1.8× 264 0.7× 85 2.3k
Carol B. Lindsley United States 25 720 0.4× 662 0.5× 239 0.2× 392 0.9× 226 0.6× 54 2.1k
Deborah M. Levy Canada 23 973 0.6× 439 0.3× 590 0.5× 159 0.4× 137 0.4× 99 1.8k

Countries citing papers authored by Jon Packham

Since Specialization
Citations

This map shows the geographic impact of Jon Packham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Packham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Packham more than expected).

Fields of papers citing papers by Jon Packham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Packham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Packham. The network helps show where Jon Packham may publish in the future.

Co-authorship network of co-authors of Jon Packham

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Packham. A scholar is included among the top collaborators of Jon Packham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Packham. Jon Packham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Packham, Jon, James Galloway, Jonathan Hill, et al.. (2024). E041 Feasibility and acceptability of electronic patient reported outcome measures in the routine care of people with inflammatory arthritis: Haywood Arthritis Portal study. Lara D. Veeken. 63(Supplement_1). 1 indexed citations
3.
Helliwell, Philip, Laura C. Coates, Jon Packham, et al.. (2023). The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study. Lara D. Veeken. 63(4). 991–998. 2 indexed citations
4.
Hailey, Louise, Christine Bundy, David Chandler, et al.. (2022). The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership. Lara D. Veeken. 62(8). 2716–2723. 11 indexed citations
6.
Packham, Jon, et al.. (2022). Diagnostic delay in axial spondyloarthritis: a systematic review. Clinical Rheumatology. 41(7). 1939–1950. 49 indexed citations
7.
Tillett, William, Oliver FitzGerald, Laura C. Coates, et al.. (2021). Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study. The Journal of Rheumatology. 97. jrheum.201675–jrheum.201675. 9 indexed citations
8.
Tillett, William, Oliver FitzGerald, Laura C. Coates, et al.. (2021). Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study. The Journal of Rheumatology. 97. jrheum.201674–jrheum.201674. 17 indexed citations
9.
Helliwell, Philip, William Tillett, Robin Waxman, et al.. (2021). Evaluation and Validation of a Patient-completed Psoriatic Arthritis Flare Questionnaire. The Journal of Rheumatology. 48(8). 1268–1271. 4 indexed citations
10.
Al‐Mossawi, Hussein, Chris Worth, Patrícia Maria Abreu Machado, et al.. (2021). A first in disease phase 2A trial of granulocyte monocyte colony stimulating factor neutralisation for axial spondyloarthritis (NAMASTE study). Clinical and Experimental Rheumatology. 39(5). 1161–1161.
11.
Tillett, William, Neil McHugh, Ana‐Maria Orbai, et al.. (2020). Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps. The Journal of Rheumatology. 96. 11–18. 20 indexed citations
12.
Packham, Jon, Paul Creamer, Kuntal Chakravarty, et al.. (2017). Clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial.. PubMed. 35(3). 445–451. 9 indexed citations
14.
Roddy, Edward, Kelvin P. Jordan, Raymond Oppong, et al.. (2016). Reconsultation, self-reported health status and costs following treatment at a musculoskeletal Clinical Assessment and Treatment Service (CATS): a 12-month prospective cohort study. BMJ Open. 6(10). e011735–e011735. 2 indexed citations
15.
Packham, Jon, et al.. (2013). Health Workforce in Nevada 2013 Edition. 1 indexed citations
16.
Hider, Samantha, et al.. (2012). Fibromyalgia in patients with rheumatoid arthritis: driven by depression or joint damage?. PubMed. 29(6 Suppl 69). S88–91. 18 indexed citations
17.
Rafia, Rachid, Roberta Ara, Jon Packham, Kirstie Haywood, & Emma L. Healey. (2012). Healthcare costs and productivity losses directly attributable to ankylosing spondylitis.. PubMed. 30(2). 246–53. 33 indexed citations
18.
Kingsley, Gabrielle, Anna Kowalczyk, Fowzia Ibrahim, et al.. (2012). A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Lara D. Veeken. 51(8). 1368–1377. 233 indexed citations
19.
Chen, Ying, P. T. Dawes, Jon Packham, & Derek L. Mattey. (2011). Interaction Between Smoking and Polymorphism in the Promoter Region of the VEGFA Gene Is Associated with Ischemic Heart Disease and Myocardial Infarction in Rheumatoid Arthritis. The Journal of Rheumatology. 38(5). 802–809. 31 indexed citations
20.
Packham, Jon & M A Hall. (2003). Premature ovarian failure in women with juvenile idiopathic arthritis (JIA).. PubMed. 21(3). 347–50. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026